Bacteriocins and novel bacterial strains
AssigneesThe United States of America as represented by the Secretary of Agriculture, State Research Center for Applied Microbiology & Biotechnology, Ministry of Health & Social Development, RF, as represented by the Director of the State Research Center for Applied Microbiology & Biotechnology Ministry of Health & Social Development, RF
InventorsNorman J Stern, Edward A Svetoch, Boris V Eruslanov, Vladimir V Perelygin, Vladimir P Levchuk, Nikolay N Urakov, Larisa I Volodina, Yuri N. Kovalev, Tamara Y. Kudryavtseva, Victor D. Pokhilenko, Valery N. Borzenkov, Olga E. Svetoch, Eugeni V. Mitsevich, Irina P. Mitsevich
Life of this patent
Estimating the term…
Abstract
Novel bacteriocins produced by novel bacterial strains are used for at least reducing the levels of colonization by at least one target bacteria in animals, especially poultry.
Claims4
A therapeutic feed for animals comprising:
- (a) an isolated bacteriocin produced by a Paenibacillus polymyxa strain NRRL B-30509 in amounts effective to at least reduce the levels of colonization of at least one target bacteria,
- (b) a therapeutic carrier, and
- (c) an animal feed.
A therapeutic animal feed comprising:
- (a) an isolated bacteriocin having the amino acid sequence of SEQ ID NO 2, in amounts effective to at least reduce the levels of colonization by at least one target bacteria,
- (b) a therapeutic carrier, and
- (c) an animal feed.
A therapeutic feed for animals comprising:
- (a) at least one isolated bacteriocin produced by a Paenibacillus polymyxa strain NRRL B-30509 in amounts effective to at least reduce the levels of colonization of at least one target bacteria,
- (b) a therapeutic carrier, and
- (c) an animal feed.
Dependencies are inferred from the claim text.